AAPS 2017 Development and Validation of a cGMP Compliant Particulate Characterization Database
Reference databases catalog data and information for known materials, process and product related materials, and archived foreign particulate.
RDD 2014: Chemically Specific Analysis of OINDPs: Differentiation of Drug Particle Agglomeration by Raman Chemical Imaging
Proper characterization of pharmaceutical products...
PDA 2016 Annual Meeting: Proactive Versus Reactive Testing for Glass Delamination in Pharmaceuticals
Authors & ContributorsEmily Landsperger
RDD 2015 Workshop: Assessing Aggregate Performance and the Presence of Foreign Particulate in OINDPs
May 19, 2015 Establishing bioavailability and proving bioequivalence of inhaled combination therapies can be difficult without addressing two major concerns: accurate and precise particle size distribution data of the individual active pharmaceutical ingredient and source determination of the any existing foreign particulate matter. Raman spectroscopy and Raman chemical imaging have…
Gateway Analytical to Present at 2012 MAAFS Meeting: The Introduction of Hyperspectral Imaging as an Additional Method of Examination for Tapes
Authors & Contributors Cara Plese May 10, 2012 The Mid-Atlantic Association of Forensic Scientists (MAAFS) annual meeting is being held later this month from May 14th through the 18th. MAAFS is one of several regional/state forensic science associations in the United States. Regional meetings are great for scientists to attend because they usually require less travel than…
2017 RDD Europe: Advancing the Determination of In Vitro Similarity in Tiotropium Formulations for Inhalation
Download our presentation from 2017 RDD Europe on Advancing the Determination of In Vitro Similarity in Tiotropium Formulations for Inhalation.
AAFS 2013 Presentation: What Judges and Lawyers Need to Know about the Science Behind Trace Evidence
Authors & ContributorsCara PleseAntonio Scatena
2018 PDA Annual Meeting: A Proactive Approach to the Particulate Management Lifecycle in Parenteral Drug Products
Authors & ContributorsDavid Exline, Cara Plese
2014 ASSA International IWPCPS-16 Workshops: Spatially-Resolved Raman Imaging for Ingredient-Specific Characterization of Combination Dry Powder Inhalers
June 17, 2014 Since the approval of Dry Powder Inhalers containing Fluticasone Propionate and Salmeterol Xinafoate in 1999, combination inhaled therapies have dominated the COPD market. However, due to the lack of specific guidance of the Office of Generic Drugs as to the abbreviated new drug application submission, there was…
2018 RDD Conference: Analysis of a Dry Powder Inhaler Active Pharmaceutical Ingredient Using Scanning Electron Microscopy
Download our presentation from 2018 RDD Conference on Analysis of a Dry Powder Inhaler Active Pharmaceutical Ingredient Using Scanning Electron Microscopy.